Mechanistically, BPC-157 appears to modulate angiogenesis, upregulate growth factors such as VEGF and FGF, and influence nitric oxide pathways, contributing to enhanced vascularization, tissue repair, and anti-inflammatory effects
Rather than serving as a first-line treatment, it is typically considered an adjunctive therapy that may complement more established approaches, such as physical therapy, exercise modification, and other evidence-based interventions
Together, researchers combine them to examine potential complementary mechanisms in preclinical model systems
GH and IGF-1 act synergistically with respect to growth and the kidneys and antagonistically on glucose metabolism, i.e., GH stimulates glucose synthesis and concentrations, whereas IGF-1 decreases serum glucose levels
Many users find that metabolic improvements persist for 2-4 weeks after discontinuing treatment, suggesting lasting changes in cellular function
Das bedeutet nicht automatisch, dass die Daten falsch sind, aber es bedeutet, dass externe Validierung fehlt
